Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 2 | Radiation Oncology

Fig. 2

From: Optimal dose-volume histogram thresholds for radiation pneumonitis prevention in lung cancer patients receiving immunotherapy

Fig. 2

Identification of optimal threshold of DVH parameters for the prevention of symptomatic RP. (A) Correlation analyses between V20, MLD, and V5 in the whole cohort. (B) Correlation analyses between V20, MLD, and V5 in the immune-RT cohort. (C) Receiver operating characteristic curve (ROC) analysis of V20 in the prediction of grade ≥ 2 RP in the immune-RT cohort. (D) Incidence of grade ≥ 2 RP in patients stratified by V20 at 20% in the immune-RT subgroup, No ICI subgroup and the validating cohort

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us